featured
Interleukin-1 Trap Rilonacept Beneficial in Recurrent Pericarditis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis
N. Engl. J. Med 2020 Nov 16;[EPub Ahead of Print], AL Klein, M Imazio, P Cremer, A Brucato, A Abbate, F Fang, A Insalaco, M LeWinter, BS Lewis, D Lin, SA Luis, SJ Nicholls, A Pano, A Wheeler, JF PaoliniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.